Format

Send to

Choose Destination
Oncotarget. 2015 Oct 27;6(33):34158-77. doi: 10.18632/oncotarget.5779.

Copper activates HIF-1α/GPER/VEGF signalling in cancer cells.

Author information

1
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.
2
Endocrinology, Department of Health, University Magna Graecia of Catanzaro, Catanzaro, Italy.

Abstract

Copper promotes tumor angiogenesis, nevertheless the mechanisms involved remain to be fully understood. We have recently demonstrated that the G-protein estrogen receptor (GPER) cooperates with hypoxia inducible factor-1α (HIF-1α) toward the regulation of the pro-angiogenic factor VEGF. Here, we show that copper sulfate (CuSO4) induces the expression of HIF-1α as well as GPER and VEGF in breast and hepatic cancer cells through the activation of the EGFR/ERK/c-fos transduction pathway. Worthy, the copper chelating agent TEPA and the ROS scavenger NAC prevented the aforementioned stimulatory effects. We also ascertained that HIF-1α and GPER are required for the transcriptional activation of VEGF induced by CuSO4. In addition, in human endothelial cells, the conditioned medium from breast cancer cells treated with CuSO4 promoted cell migration and tube formation through HIF-1α and GPER. The present results provide novel insights into the molecular mechanisms involved by copper in triggering angiogenesis and tumor progression. Our data broaden the therapeutic potential of copper chelating agents against tumor angiogenesis and progression.

KEYWORDS:

GPER; HIF-1α; Pathology Section; VEGF; angiogenesis; cancer; copper

PMID:
26415222
PMCID:
PMC4741443
DOI:
10.18632/oncotarget.5779
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center